Research
Pharmacogenetics
The role of genetics in response to therapeutics, pulmonary diseases, cardiovascular diseases, cancer, acute/chronic toxicities, molecular genetics of cancer, predisposition to disease, therapeutic advantage, cytochrome P450s, genetics of mammalian development.
Erica L. Woodahl, Assistant Professor, Ph.D. (pharmaceutics), University of Washington, 2004. Pharmacogenomics of drug transporters and drug-metabolizing enzymes in drug response, toxicity, and disease susceptibility.
Mark A. Pershouse, Associate Professor; Ph.D. (biomedical sciences), Texas-Houston Health Sciences Center, 1993. Molecular genetics of human cancer; genomic expression analysis for detection of toxic injury; cancer detection and diagnostics; role of SV40 virus in human cancers; bioinformatics, and mechanisms of asbestos toxicity.
Elizabeth A. Putnam, Associate Professor; Ph.D. (biomedical sciences), Texas-Houston Health Sciences Center, 1989. Gene-environment interactions in the development of disease, focusing on cancer and fibrotic disease development after asbestos exposure using both mouse models and human studies.
J. Douglas Coffin, Professor; Ph.D. (anatomy and cell biology), SUNY Health Sciences Center at Syracuse, 1989. Genetic basis of mammalian growth and development and the function of growth factors in those processes.
Todd G. Cochran, Professor Emeritus; Ph.D. (pharmaceutical sciences), Washington (Seattle), 1970. Pharmacokinetics, Cytochrome P450, educational assessment.